Health Professionals
Tertiary Syphilis-Induced Ocular Syphilis Complicated by Retinal Detachment
This journal discusses a case of tertiary syphilis leading to ocular syphilis and complications such as retinal detachment. It highlights the diagnostic challenges, treatment approaches, and clinical implications of late-stage syphilis affecting the eyes.
Treatment of Chlamydia and Gonorrhea in Primary Care and Its Patient-Level Variation: An American Family Cohort Study
This journal examines the treatment of chlamydia and gonorrhea in primary care settings and its impact on patients' subsequent health care utilization.
Trends in Cervical Precancers Identified Through Population-Based Surveillance — Human Papillomavirus Vaccine Impact Monitoring Project, Five Sites, United States, 2008–2022
This webpage discusses the significant decline in cervical precancers (CIN2+) observed between 2008 and 2022, particularly in women aged 20–24, correlating with HPV vaccination.
HCV and HIV Coinfection: Decreasing Barriers to an HCV Cure With Use of a Simplified Treatment Algorithm
This webpage explores the treatment of Hepatitis C (HCV) and HIV coinfection, addressing the complexities of managing both infections simultaneously. It discusses antiviral treatment options, potential drug interactions, and strategies for monitoring and managing the dual conditions effectively.
Association Between City-Level Sociodemographic and Health Factors and The Prevalence of Antimicrobial-Resistant Gonorrhea in the US, 2000–2019: A Spatial–Temporal Modeling Study
This journal presents a spatial–temporal modeling study examining how city-level sociodemographic and health-related factors influenced the prevalence of antimicrobial-resistant gonorrhea in the U.S. from 2000 to 2019.
Congenital Syphilis: Responding to a National Epidemic?
This video features Christopher Golden, a neonatologist at Johns Hopkins Children’s Center, discussing the alarming rise in congenital syphilis and its implications for pediatric care.
Long-Acting HIV Antiretroviral Therapy (ART): Cabotegravir/Rilpivirine (CAB/RPV)
This guideline provides recommendations for HIV care teams on implementing long-acting injectable HIV treatment, including cabotegravir and rilpivirine.
Know Your Rights: Patient Coverage of PrEP with No Cost-Sharing What You Need to Know About New Federal Guidelines
This information sheet explains the requirement for insurers to cover Pre-Exposure Prophylaxis (PrEP) without cost-sharing.
Covering Costs of HIV PrEP: E-Learning Module Tips and Resources for Covering Costs of HIV PrEP
This information sheet provides guidance on covering the costs of PrEP (Pre-Exposure Prophylaxis) and PEP (Post-Exposure Prophylaxis).